Compare GRDX & BIRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRDX | BIRD |
|---|---|---|
| Founded | N/A | 2015 |
| Country | United Kingdom | United States |
| Employees | 2 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.6M | 26.2M |
| IPO Year | N/A | 2021 |
| Metric | GRDX | BIRD |
|---|---|---|
| Price | $2.90 | $2.22 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 59.3K | ★ 330.4K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.22 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $152,466,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $35.12 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.87 | $2.15 |
| 52 Week High | $6.93 | $24.31 |
| Indicator | GRDX | BIRD |
|---|---|---|
| Relative Strength Index (RSI) | 38.29 | 28.39 |
| Support Level | $2.01 | $2.23 |
| Resistance Level | $3.65 | $3.36 |
| Average True Range (ATR) | 0.40 | 0.17 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 26.79 | 5.38 |
GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
Allbirds Inc is a lifestyle brand that innovates with naturally derived materials to make footwear and apparel products in a better way, while treading lighter on the planet. Its primary source of revenue is from sales of shoes and apparel products. The majority of the revenue is derived from United States.